Title: β-D-glucosyl conjugates of highly potent inhibitors of blood coagulation factor Xa bearing 2-chorothiophene as a P1 motif.
Journal: ChemMedChem 20120901
Title: Mechanistic studies on the Pd-catalyzed direct C-H arylation of 2-substituted thiophene derivatives with arylpalladium bipyridyl complexes.
Journal: Chemistry, an Asian journal 20120601
Title: Positive and negative photoion spectroscopy study of monochlorothiophenes.
Journal: The journal of physical chemistry. A 20111013
Title: (2E)-1-(5-Chloro-thio-phen-2-yl)-3-(2,3-dimeth-oxy-phen-yl)prop-2-en-1-one.
Journal: Acta crystallographica. Section E, Structure reports online 20111001
Title: (2E)-1-(5-Chloro-thio-phen-2-yl)-3-(2,4,5-trimeth-oxy-phen-yl)prop-2-en-1-one.
Journal: Acta crystallographica. Section E, Structure reports online 20110801
Title: Theoretical study on the electronic, structural, properties and reactivity of a series of mono-, di-, tri- and tetrachlorothiophenes as well as corresponding radical cation forms as monomers for conducting polymers.
Journal: Chemistry Central journal 20110101
Title: Entering the era of non-basic p1 site groups: discovery of Xarelto (Rivaroxaban).
Journal: Current topics in medicinal chemistry 20100101
Title: In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20090501
Title: Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.
Journal: Vascular health and risk management 20081201
Title: Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor.
Journal: Journal of medicinal chemistry 20050922
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology 20050601
Title: Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket.
Journal: Journal of medicinal chemistry 20030227